ArticleLife (Basel, Switzerland)2022

High Post-Treatment Leptin Concentration as a Prognostic Biomarker of the High Risk of Luminal Breast Cancer Relapse: A Six-Year Comprehensive Study.

Katarzyna Kwiatkowska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.